The IPO comprises a fresh issue of 45.84 lakh equity shares through the book-building route
Read More
This novel anti-infective, invented by Orchid Pharma, aims to address the rising threat of antimicrobial resistance (AMR) and has been approved for the treatment of complicated urinary tract infections (cUTI), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP)
Read More
Research by the American Medical Association (AMA) supports this digital transformation, finding that 9 in 10 physicians see benefits in digital health tools
Read More
This marks India’s second youngest case of a successful cochlear implant
Read More
This acquisition is expected to enhance HCG's annual EBITDA by Rs 3 per share
Read More
